Last month, PharmaShots was all about the infusion of cutting-edge technological advances into the life science industry. Our most read Top 20 covered Diagnostic Companies based on the total revenue in 2022 and Top 20 Nutraceutical Companies based on 2022 segment revenue. PharmaShots, like every month presented a detailed report on its informative disease of the month section covering Scleroderma. Our report on the Product of the month navigated through one of the Top-performing drugs Enbrel. Like every month PharmaShots acquainted its readers with key biosimilar development, FDA & EMA approvals
PharmaShots’ ThoughtSpot section featured a comprehensive article on the use of Intelligent Automation in Pharmaceutical Industry and covered the new Pilot program launched by FDA to regulate LDTs used to develop cancer biomarkers. ThoughtSpot also featured two guest posts on Revolutionizing Life Insurance & Multichannel Marketing Tactics in Pharma.
In associations with Agilent Technologies, PharmaShots hosted a webinar on Levelling up Lab Skills.
Get a chance to be featured in our magazine! Submit your white papers, advertisements, and interviews by reaching out to us at connect@pharmashots.com
